Drugs News and Research

RSS

Researchers develop new strategy in the search for psychoactive drugs

Researchers at the University of Zurich and Harvard University have developed a new strategy in the search for psychoactive drugs.

1 Nov 2018

Researchers uncover link between RNA abnormalities and multiple myeloma progression

Multiple myeloma is the second most common type of blood cancer where cancer cells accumulate in the bone marrow, crowding out healthy blood cells.

1 Nov 2018

Scientists working hard to better understand endometriosis

About 10 percent of women worldwide suffer from endometriosis, a painful and debilitating disease with inadequate treatments.

1 Nov 2018

UA scientists aim to identify drug targets for rare pediatric cancer

Rhabdomyosarcoma is a rare cancer of the skeletal muscle that primarily affects pediatric patients. After diagnosis, about 3 out of 4 patients are cured with standard treatment. Survival rates drop to 17 percent if the disease comes back (recurs) and to 30 percent if it spreads (metastasizes).

1 Nov 2018

FDA permits marketing of 23andme Personal Genome Service Pharmacogenetic Reports test

Today, the U.S. Food and Drug Administration permitted marketing, with special controls, of the 23andme Personal Genome Service Pharmacogenetic Reports test as a direct-to-consumer test for providing information about genetic variants that may be associated with a patient's ability to metabolize some medications to help inform discussions with a health care provider.

1 Nov 2018

Two-cells-in-one combo therapy shows promise in strengthening leukemia treatment

A cancer therapy based on fusing two types of cells into a single unit shows promise in strengthening existing treatments for acute myeloid leukemia. The approach joins blood platelets that carry cancer drugs with stem cells that guide the platelets into bone marrow where leukemia begins.

31 Oct 2018

Cytokine levels could predict autoimmune reactions to cancer immunotherapy

The development of immunotherapy, which mobilizes the body's own immune system to destroy cancer cells, is one of the greatest advances in cancer treatment, but immunotherapy can cause harm to healthy tissue in some patients.

31 Oct 2018

Scientists identify 'skeleton key' for congenital kidney disease research

Scientists in Japan have found a 'skeleton key' for congenital kidney disease research. Using iPS cells generated from the skin cells of a patient with a nephrin mutation, Kumamoto University scientists have successfully developed kidney tissue that exhibits the early stages of congenital kidney disease.

31 Oct 2018

Doctors find no association between autism and drugs taken during pregnancy

A new study has found that babies exposed to medications in the womb are at no more risk of developing autism than babies who are not exposed to any drugs.

31 Oct 2018

Researchers discover how protein pair regulates cellular calcium signals

All mammalian cells need a ready supply of calcium ions to execute functions as diverse as neurotransmission, muscle contraction, hormone release, or immune responses. So fundamental is this requirement that cells protect themselves from disaster by storing calcium in a network of intracellular cisterns called the endoplasmic reticulum, or ER.

31 Oct 2018

New drug discovery will increase safety of canine sedation and anesthesia

A drug discovery made at the University of Helsinki's Faculty of Veterinary Medicine will increase the safety of animal sedation and anesthesia. Vatinoxan, the pharmacological molecule discovered in the study, reduced the adverse effects of other drugs on the cardiovascular system of canine patients.

31 Oct 2018

Alzheimer's Association's Part the Cloud program funds innovative research on brain cells

Innovative research aimed to possibly rejuvenate brain cells will be explored by six international researchers with the goal of discovering effective drugs for people with early stage Alzheimer's disease and other dementias.

31 Oct 2018

Study on how blood clots form and clear could make pancreatic cancer more treatable

You're experiencing jaundice, abdominal pain or constipation. And by then, you may be too late. Pancreatic cancer symptoms often arrive after the cancer has already spread, making the disease one of the leading causes of cancer deaths in the U.S.

31 Oct 2018

Texas A&M study identifies new brain region involved in inhibiting fear

A study conducted at Texas A&M University has identified a new area in the brain involved in inhibiting fear, a discovery that holds potential for clinical interventions in patients with psychiatric diseases such as post-traumatic stress disorder.

31 Oct 2018

Study explores impact of new Texas law HB 810 on stem cell interventions

A new study takes a close look at the content and potential implications of the new Texas law HB 810, which aims to expand assess of experimental stem cell interventions outside the realm of clinical trials under FDA oversight.

31 Oct 2018

Researchers develop diagnostic test to determine risk of developing malignant breast cancer

Currently, with a pre-malignant breast cancer diagnosis from a biopsy, there are three options: observation, chemoprevention or surgery, all of which require a patient to make decisions while operating from a place of fear and unknown outcomes.

31 Oct 2018

UA pharmacology professors aim to avoid opioid analgesic tolerance

For thousands of Americans, opioids no longer relieve pain -- they cause pain. Known as "opioid tolerance," patients eventually become desensitized to opioids and more sensitive to pain after years of using the pain relievers.

31 Oct 2018

Study shows how machinery within immune system activates T cells to attack cancer

In just a few years, CAR T-cell and other adoptive T-cell therapies have emerged as among the most promising forms of cancer immunotherapy.

31 Oct 2018

Scientists describe novel conjugates made from antibodies and protein inhibitor

Linking therapeutically active molecules to specific antibodies can help to pilot them to their designated targets and minimize side effects--especially when treating tumors. In the journal Angewandte Chemie, scientists have now described novel conjugates made from antibodies and a kinesin spindle protein inhibitor.

31 Oct 2018

Scientists pinpoint TIM-3 protein as next potential target for immunotherapy treatments

Following the 2018 Nobel Prize for Medicine, global attention is now more than ever turned toward the promise of immunotherapy in oncology. An international team’s work has shed new light on a molecule called TIM-3 that might play a key role in the regulation of the immune response.

31 Oct 2018

Drugs News and Research

Researchers develop new strategy in the search for psychoactive drugs

Researchers uncover link between RNA abnormalities and multiple myeloma progression

Scientists working hard to better understand endometriosis

UA scientists aim to identify drug targets for rare pediatric cancer

FDA permits marketing of 23andme Personal Genome Service Pharmacogenetic Reports test

Two-cells-in-one combo therapy shows promise in strengthening leukemia treatment

Cytokine levels could predict autoimmune reactions to cancer immunotherapy

Scientists identify 'skeleton key' for congenital kidney disease research

Doctors find no association between autism and drugs taken during pregnancy

Researchers discover how protein pair regulates cellular calcium signals

New drug discovery will increase safety of canine sedation and anesthesia

Alzheimer's Association's Part the Cloud program funds innovative research on brain cells

Study on how blood clots form and clear could make pancreatic cancer more treatable

Texas A&M study identifies new brain region involved in inhibiting fear

Study explores impact of new Texas law HB 810 on stem cell interventions

Researchers develop diagnostic test to determine risk of developing malignant breast cancer

UA pharmacology professors aim to avoid opioid analgesic tolerance

Study shows how machinery within immune system activates T cells to attack cancer

Scientists describe novel conjugates made from antibodies and protein inhibitor

Scientists pinpoint TIM-3 protein as next potential target for immunotherapy treatments

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News